CoChat

Cancer‐associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells

Open access
Fuyuhiro, Yuhiko, Yashiro, Masakazu, Noda, Satoru, Matsuoka, Junko, Hasegawa, Tsuyoshi, Kato, Yukihiro, Sawada, Tetsuji, Hirakawa, Kosei · 2012 · Cancer Science
Cited by 62

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Tumor progression has been recognized as the product of evolving crosstalk between cancer cells and the surrounding stromal cells. Cancer‐associated orthotopic myofibroblasts may be linked to the progression of gastric carcinomas. To understand the significance of orthotopic myofibroblasts, we examined the effects of cancer‐associated orthotopic myofibroblasts on the malignant phenotype of gastric cancer cells. Three human gastric cancer cell lines (OCUM‐2 MD 3, OCUM‐12, MKN‐45) and four human gastric fibroblast cell lines (cancer‐associated orthotopic fibroblast [C a F]‐29, C a F‐33, normal orthotopic fibroblast [NF]‐29, NF‐33) were used. The cancer‐associated orthotopic fibroblast cell lines C a F‐29 and C a F‐33 were established from a tumoral gastric wall, and normal orthotopic fibroblast NF‐29 and NF‐33 were established from a non‐tumoral gastric wall. Fibroblasts that were α‐smooth muscle actin‐positive were defined as myofibroblasts. We examined the effects of cancer‐associated orthotopic myofibroblasts on the aggressiveness of gastric cancer cells by wound‐healing assay, invasion assay, and RT‐PCR. The ratios of myofibroblasts in C a F‐29 (33%) and C a F‐33 (46%) were significantly (P < 0.001) greater than those in NF‐29 (11%) or NF‐33 (13%). Although all four orthotopic fibroblast lines increased the motility of gastric cancer cells, including migration and invasion ability, the motility‐stimulating activity of cancer‐associated fibroblasts (C a F‐29 and C a F‐33) was significantly higher than that of normal fibroblasts (NF‐29 and NF‐33). These motility‐stimulating activities of cancer‐associated orthotopic fibroblasts were downregulated by Smad2 si RNA treatment and anti‐transforming growth factor‐β neutralizing antibody. These findings suggest that cancer‐associated orthotopic myofibroblasts may play an important role in the progression of gastric cancers and that transforming growth factor‐β produced by myofibroblasts may be one of the factors associated with the aggressiveness of gastric carcinoma cells. (Cancer Sci 2012; 103: 797–805)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1349-7006.2012.02209.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 62

Metadata

Authors
Fuyuhiro, Y., Yashiro, M., Noda, S., Matsuoka, J., Hasegawa, T., Kato, Y., Sawada, T., & Hirakawa, K.
Venue
Cancer Science
Publisher
Wiley
Published
2012-02-15
Volume
103
Issue
4
Pages
797-805
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W2048575901
Cited by
62
References
2
FWCI
2.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer‐associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells. https://app.cochat.ai/papers/10.1111/j.1349-7006.2012.02209.x
The paper
Fuyuhiro, Y., Yashiro, M., Noda, S., Matsuoka, J., Hasegawa, T., Kato, Y., Sawada, T., & Hirakawa, K. (2012). Cancer‐associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells. Cancer Science. https://doi.org/10.1111/j.1349-7006.2012.02209.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.